0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover0.00%IV-66.86%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma12.07Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Zentalis Pharmaceuticals Stock Discussion
• $Enphase Energy(ENPH.US)$ +8.2% (earnings reports)
• $Zentalis Pharmaceuticals(ZNTL.US)$ +7.6% (announces $25 mln equity investment from Pfizer (PFE); enters into development collaboration for ZN-c3)
• $Ternium(TX.US)$ +6.1% (earnings reports)
• $PureCycle Technologies(PCT.US)$ +5% (SEC concludes investigation without further action)
• $Alliance Resource(ARLP.US)$ +4.7% (increases dividend; provides prelim qtrly results)
• $Digital World Acquisition Corp(DWAC.US)$ +4.5% (cu...
• $Banc of California(BANC.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $Cullen/Frost Bankers(CFR.US)$: Raymond James Upgrades to Outperform from Market Perform
• $W.W. Grainger(GWW.US)$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes Inc(INVH.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp(PCB.US)$: Raymond James Upgrades to Outperform from Market Perfor...
No comment yet